Citigroup’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-932
Closed -$499 6112
2024
Q4
$499 Sell
932
-374
-29% -$261 ﹤0.01% 5625
2024
Q3
$2.3K Sell
1,306
-55,262
-98% -$77.1K ﹤0.01% 5405
2024
Q2
$66.2K Buy
56,568
+42,856
+313% +$107K ﹤0.01% 4431
2024
Q1
$124K Buy
13,712
+5,525
+67% +$53.7K ﹤0.01% 4212
2023
Q4
$89K Buy
8,187
+7,532
+1,150% +$56.4K ﹤0.01% 4246
2023
Q3
$5.27K Sell
655
-15,041
-96% -$125K ﹤0.01% 4707
2023
Q2
$170K Sell
15,696
-89,590
-85% -$767K ﹤0.01% 3962
2023
Q1
$726K Buy
105,286
+29,483
+39% +$185K ﹤0.01% 2824
2022
Q4
$302K Buy
75,803
+67,299
+791% +$331K ﹤0.01% 3502
2022
Q3
$57K Buy
8,504
+7,064
+491% +$43.5K ﹤0.01% 4335
2022
Q2
$7K Sell
1,440
-1,540
-52% -$9.37K ﹤0.01% 5517
2022
Q1
$28K Sell
2,980
-8,260
-73% -$82.1K ﹤0.01% 4986
2021
Q4
$134K Sell
11,240
-5,623
-33% -$64.9K ﹤0.01% 4577
2021
Q3
$192K Buy
16,863
+11,234
+200% +$154K ﹤0.01% 4133
2021
Q2
$101K Buy
5,629
+1,390
+33% +$22.4K ﹤0.01% 4514
2021
Q1
$65K Sell
4,239
-5,282
-55% -$76.4K ﹤0.01% 4567
2020
Q4
$116K Buy
9,521
+8,320
+693% +$116K ﹤0.01% 5424
2020
Q3
$15K Sell
1,201
-1,707
-59% -$14.7K ﹤0.01% 6386
2020
Q2
$30K Sell
2,908
-3,048
-51% -$28K ﹤0.01% 6333
2020
Q1
$48K Buy
5,956
+3,378
+131% +$29.3K ﹤0.01% 6005
2019
Q4
$22K Buy
2,578
+1,135
+79% +$6.37K ﹤0.01% 6899
2019
Q3
$9K Sell
1,443
-2,072
-59% -$16.7K ﹤0.01% 7144
2019
Q2
$59K Buy
3,515
+211
+6% +$3.67K ﹤0.01% 6324
2019
Q1
$55K Buy
3,304
+916
+38% +$13.2K ﹤0.01% 6271
2018
Q4
$28K Buy
2,388
+166
+7% +$3.36K ﹤0.01% 6700
2018
Q3
$89K Buy
2,222
+1,209
+119% +$34.4K ﹤0.01% 6019
2018
Q2
$29K Buy
1,013
+968
+2,151% +$21.5K ﹤0.01% 6719
2018
Q1
$1K Sell
45
-274
-86% -$6.52K ﹤0.01% 7480
2017
Q4
$10K Buy
+319
New +$8.6K ﹤0.01% 7055
2015
Q4
Sell
-6
Closed 7929
2015
Q3
$0 Sell
6
-8
-57% -$451 ﹤0.01% 7787
2015
Q2
$1K Buy
+14
New +$523 ﹤0.01% 7358